We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$18B
AUM Growth
+$622M
Cap. Flow
+$255M
Cap. Flow %
1.42%
Top 10 Hldgs %
56.54%
Holding
1,178
New
153
Increased
440
Reduced
373
Closed
159

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$31.7M
2
UUUU icon
Energy Fuels
UUUU
+$26.2M
3
NEM icon
Newmont
NEM
+$24.4M
4
LYB icon
LyondellBasell Industries
LYB
+$22.6M
5
MSM icon
MSC Industrial Direct
MSM
+$20.5M

Sector Composition

Rank Sector Weight
1 Energy 65.77%
2 Materials 4.62%
3 Technology 4.08%
4 Financials 3.42%
5 Consumer Discretionary 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMPS
1001
Compass Pathways
CMPS
$1.52B
$259K ﹤0.01%
45,203
-5,230
-10% -$23.5K
PRTA icon
1002
Prothena Corp
PRTA
$458M
$251K ﹤0.01%
25,727
-3,301
-11% -$25.4K
ARCT icon
1003
Arcturus Therapeutics
ARCT
$157M
$241K ﹤0.01%
13,101
-1,518
-10% -$24.4K
RGNX icon
1004
Regenxbio
RGNX
$623M
$239K ﹤0.01%
24,717
-2,328
-9% -$20.6K
MLTX icon
1005
MoonLake Immunotherapeutics
MLTX
$1.59B
$221K ﹤0.01%
30,756
-3,534
-10% -$184K
CRML icon
1006
Critical Metals Corp
CRML
$853M
$214K ﹤0.01%
34,336
-5,338
-13% -$27.4K
AUTL
1007
Autolus Therapeutics
AUTL
$386M
$203K ﹤0.01%
124,606
-19,008
-13% -$37.1K
ATXS
1008
DELISTED
Astria Therapeutics
ATXS
$190K ﹤0.01%
26,161
-4,263
-14% -$28.8K
BCYC
1009
Bicycle Therapeutics
BCYC
$270M
$187K ﹤0.01%
24,123
-1,634
-6% -$12.3K
DCTH icon
1010
Delcath Systems
DCTH
$422M
$181K ﹤0.01%
16,874
-1,949
-10% -$21.8K
CAPR icon
1011
Capricor Therapeutics
CAPR
$1.14B
$159K ﹤0.01%
22,112
-2,559
-10% -$18.8K
REPL icon
1012
Replimune Group
REPL
$814M
$156K ﹤0.01%
37,287
-4,315
-10% -$27.6K
ANNX icon
1013
Annexon
ANNX
$855M
$146K ﹤0.01%
47,879
-11,322
-19% -$28.1K
RC
1014
Ready Capital
RC
$265M
$143K ﹤0.01%
37,002
VNDA icon
1015
Vanda Pharmaceuticals
VNDA
$312M
$139K ﹤0.01%
27,925
-3,834
-12% -$17.8K
CADL icon
1016
Candel Therapeutics
CADL
$700M
$134K ﹤0.01%
26,278
-767
-3% -$4.43K
AVIR icon
1017
Atea Pharmaceuticals
AVIR
$379M
$107K ﹤0.01%
36,751
-9,414
-20% -$32.1K
SITC icon
1018
SITE Centers
SITC
$230M
$92.3K ﹤0.01%
10,243
ATLX icon
1019
Atlas Lithium Corp
ATLX
$82.3M
$57K ﹤0.01%
+11,966
New +$59.1K
A icon
1020
Agilent Technologies
A
$39.1B
-13,343
Closed -$1.57M
ACMR icon
1021
ACM Research
ACMR
$5.83B
-12,130
Closed -$314K
ADEA icon
1022
Adeia
ADEA
$2.86B
-26,787
Closed -$379K
ADMA icon
1023
ADMA Biologics
ADMA
$1.92B
-19,484
Closed -$355K
AMAL icon
1024
Amalgamated Financial
AMAL
$1.48B
-12,246
Closed -$382K
AMSF icon
1025
AMERISAFE
AMSF
$569M
-105,941
Closed -$4.63M

Similar funds

ALPS Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, ALPS Advisors held 1,178 positions worth $18B, up 3.6% from $17.3B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

ALPS Advisors's Q3 2025 filing shows 153 new, 440 increased, 373 reduced and 159 closed positions. Its largest new stake was LKQ Corp: 616,648 shares worth $18.8M. The largest sale was Cameco, an estimated $31.7M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 68% a quarter earlier, followed by Materials and Technology.

  • ALPS Advisors's largest Q3 2025 buy was LKQ Corp: 616,648 shares worth $18.8M.
  • ALPS Advisors added most to Energy Transfer Partners in Q3 2025, an estimated $59M increase.
  • ALPS Advisors's biggest Q3 2025 reduction was Cameco, cutting an estimated $31.7M.
  • ALPS Advisors fully exited LyondellBasell Industries in Q3 2025, selling an estimated $22.6M.
  • ALPS Advisors's ten largest holdings make up 57% of its $18B portfolio in Q3 2025.
  • ALPS Advisors opened 153 new positions and closed 159 in Q3 2025.
  • ALPS Advisors's portfolio value rose 3.6% quarter-over-quarter to $18B.

Based on ALPS Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.